Speaker Profile

___	__
	Biography Dr. Ogilvie is a Tier 1 Canada Research Chair in Global Control of HPV related diseases and prevention, and Professor at UBC in the School of Population and Public Health. She is also Senior Public Health Scientist at BC Centre for Disease Control and Senior Research Advisor at the BC Women’s Hospital and Health Centre. Her research is focused on both the public health and clinical aspects of reproductive health, sexually transmitted infections, HPV screening and the HPV vaccine, and her findings have been highly influential in setting and directing health policy both in Canada and globally (ASPIRE program, HPV FOCAL and QUEST). She has published over 150 peer reviewed manuscripts and has provided advice and consultation to national and global institutions. Dr. Ogilvie received her MD from McMaster University, and completed a specialty in Family Medicine and a fellowship in Population Health and Primary care. She received her Master of Science at UBC, and her Doctorate in Public Health from the University of North Carolina Gillings School of Global Public Health. Dr. Ogilvie is the recipient of several honors. In 2019, she was part of the Governor General’s Official Delegation to the 25th Commemoration of the Rwandan Genocide. She is one of the inaugural recipients of the highly prestigious CIHR ‘Foundation Grant’ awards. Disclosure I do not have a relationship with a for-profit and/or a not-for-profit organization to disclose. I do not intend to make therapeutic recommendations for medications that have not received regulatory approval (i.e. “off-label” use of medication).

Biography
Dr. Ogilvie is a Tier 1 Canada Research Chair in Global Control of HPV related diseases and prevention, and Professor at UBC in the School of Population and Public Health. She is also Senior Public Health Scientist at BC Centre for Disease Control and Senior Research Advisor at the BC Women’s Hospital and Health Centre. Her research is focused on both the public health and clinical aspects of reproductive health, sexually transmitted infections, HPV screening and the HPV vaccine, and her findings have been highly influential in setting and directing health policy both in Canada and globally (ASPIRE program, HPV FOCAL and QUEST). She has published over 150 peer reviewed manuscripts and has provided advice and consultation to national and global institutions. Dr. Ogilvie received her MD from McMaster University, and completed a specialty in Family Medicine and a fellowship in Population Health and Primary care. She received her Master of Science at UBC, and her Doctorate in Public Health from the University of North Carolina Gillings School of Global Public Health. Dr. Ogilvie is the recipient of several honors. In 2019, she was part of the Governor General’s Official Delegation to the 25th Commemoration of the Rwandan Genocide. She is one of the inaugural recipients of the highly prestigious CIHR ‘Foundation Grant’ awards.
Disclosure
I do not have a relationship with a for-profit and/or a not-for-profit organization to disclose. I do not intend to make therapeutic recommendations for medications that have not received regulatory approval (i.e. “off-label” use of medication).